BIOA Latest Press Releases

-- December 4, 2025 --

BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor Globe Newswire 9:00 AM

-- November 25, 2025 --

BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference Globe Newswire 4:30 PM

-- November 7, 2025 --

BioAge Labs to Present at Jefferies Global Healthcare Conference in London Globe Newswire 9:00 AM

-- November 6, 2025 --

BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 4:45 PM

-- October 2, 2025 --

BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm Globe Newswire 7:27 AM

-- September 15, 2025 --

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor PRNewswire 9:30 AM

-- August 20, 2025 --

BioAge Labs to Present at Upcoming Investor Conferences Globe Newswire 4:30 PM

-- August 6, 2025 --

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software